Print

Purpose

This protocol describes pilot testing of an educational shared decision-making intervention to help men with localized prostate cancer make decisions with their health care providers about if and when to de-escalate surveillance testing. The project is important because for many patients their cancer does not progress to the point of needed curative treatment or their health status changes such that they are no longer good candidates for treatment. For these men, de-escalating ongoing surveillance (e.g., fewer biopsies or imaging studies) is a reasonable option.

Condition

Eligibility

Eligible Ages
Over 65 Years
Eligible Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

Patients: 1. Males aged 65 or older 2. Diagnosis of localized prostate cancer 3. Have not received curative intent treatment for their prostate cancer 4. Fluent in English Care partners/caregivers: 1. Aged 18 or older 2. Fluent in English 3. Involved with the care of an eligible patient (i.e. partner, close friend, family member, companion)

Exclusion Criteria

Patients 1. Currently receiving treatment for another cancer (primary or recurrence) Care partners/caregivers 1. None

Study Design

Phase
Study Type
Observational
Observational Model
Other
Time Perspective
Other

Recruiting Locations

M.D. Anderson Cancer Center
Houston, Texas 77030
Contact:
Lisa Lowenstein, MD
713-563-0020
deescalatepca@mdanderson.org

More Details

Status
Recruiting
Sponsor
M.D. Anderson Cancer Center

Study Contact

Lisa Lowenstein, MD
713-563-0020
deescalatepca@mdanderson.org

Detailed Description

Primary Objective: The overall goal of this protocol is to test initial efficacy of three versions of an educational tool for use by patients and health-care providers to help men with localized prostate cancer make informed decisions about discontinuation of active surveillance. A pre-post design was selected to provide initial efficacy data of the different versions of the shared decision-making intervention. Thereby, providing preliminary data in preparation for a follow-up comparative study.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.